RCT of Mediterranean diet and fecal microbiota transplant on aging markers in adults over 40
This is a randomized controlled trial comparing four arms over 8 weeks: Mediterranean-style diet alone, fecal microbiota transplant (FMT) alone, combined diet plus FMT, and placebo FMT in participants aged 40 and older. The study measures changes in inflammatory markers and biological aging biomarkers, with secondary outcomes including microbiome composition, metabolites, diet adherence, and quality of life.
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Sep 17, 2026 · Discovered: Sep 19, 2026 · Assessed: — · Research update
What it does not prove
- Limitations have not yet been verified. Read the primary source.
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Rct
- Sample size
- —
- Duration
- 3 months
- Population
- Participants aged ≥40 years
- Primary outcome
- change from baseline to end of dietary intervention (week 8) in markers of aging and inflammation
- Effect size
- —
- Significance
- Not reported
- Journal
- Stanford University
- Published
- Sep 17, 2026
Sources
Primary source
- Stanford University ↗Clinical trial
Assessment history
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
No comments yet
Be the first to weigh in on this evidence.